Sun Pharmaceutical Industries has initiated a Shareholder Satisfaction Survey to gather critical feedback on the services provided by its Registrar and Transfer Agent (RTA), MUFG Intime India Private Limited. The Survey is specifically targeted at shareholders who utilized RTA services between 1 April 2025 and 31 December 2025. The company seeks constructive feedback to enhance service quality and responsiveness, with the survey running from 17 March 2026 until 31 March 2026.
Shareholder Engagement Initiative Announced
Sun Pharmaceutical Industries Limited announced the launch of a dedicated Shareholder Satisfaction Survey (“Survey”) as part of its commitment to continuously improve services offered through its Registrar and Transfer Agent (RTA). The company highly values shareholder relationships and uses these periodical reviews to bolster efficiency, service quality, and responsiveness.
Survey Details and Timeline
The Survey is designed to seek constructive, experience-based feedback concerning the services provided by the RTA, which is currently MUFG Intime India Private Limited (formerly Link Intime India Private Limited).
- Survey Commencement Date: 17 March 2026
- Survey Closing Date: 31 March 2026
Eligibility for Participation
Participation in this crucial feedback mechanism is strictly limited to shareholders who have actively availed themselves of the RTA services during a defined prior period:
Shareholders who used RTA services from 1 April 2025 to 31 December 2025 are eligible. The Company confirmed that specific communication, including the Survey link, is being delivered via email to these relevant shareholders.
Call to Action
Sun Pharma strongly encourages all eligible shareholders to actively participate. The valuable feedback gathered is expected to play a vital role in the company’s ongoing strategy to further strengthen shareholder services and overall engagement.
The communication was authorized by Anoop Deshpande, Company Secretary and Compliance Officer, on 17 March 2026.
Source: BSE
